BIG DATA ANALYTICS IN PHARMACOVIGILANCE - A GLOBAL TREND
| Autor: | Bhuvaneshwari E, Sravani Marpaka, Chakradhar T, Swetha Rani Aitha, Swarupa Rani Kasukurthi |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) education Big data Pharmaceutical Science Medical information Listing (computer) Health records Data science Pharmacovigilance Pharmacology (medical) Business |
| Zdroj: | Asian Journal of Pharmaceutical and Clinical Research. :19-24 |
| ISSN: | 2455-3891 0974-2441 |
| DOI: | 10.22159/ajpcr.2021.v14i10.42765 |
| Popis: | Big data analysis has enhanced its demand nowadays in various sectors of health-care including pharmacovigilance. The exact definition of big data is not known to many people though it is routinely used by them. Big data refer to immense and voluminous computerized medical information which are obtained from electronic health records, administrative data, registries related to disease, drug monitoring, etc. This data are usually collected from doctors and pharmacists in a health-care facility. Analysis of big data in pharmacovigilance is useful for early raising of safety alerts, line listing them for signal detection of drugs and vaccines, and also for their validation. The present paper is intended to discuss big data analytics in pharmacovigilance focusing on global prospect and domestic country-India. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|